5/17/2023 0 Comments Fmail genitle herpes![]() ![]() ![]() biopharmaceutical company, Genocea Biosciences, Inc., announced this week positive 12 month efficacy data from its Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. Giles Laboratory of Human Genetics of Infectious Diseases (J.C., J.-L.C., S.-Y.Z.), Rockefeller Branch, The Rockefeller University, New York, NY Department of Neurology (L.T., S.W.), Oulu University Hospital Institute for Molecular Medicine Finland (J.L., J.S.), HiLIFE, and The Folkhälsan Research Center and Medicum (J.L.), University of Helsinki, Finland Centre for Molecular Medicine Norway (J.S.), University of Oslo, Norway Department of Clinical Genetics (M.K., O.K.), Oulu University Hospital, Finland Department of Medical Microbiology (T.V.), Turku University Hospital and Institute of Biomedicine, University of Turku, Finland Department of Clinical Neurophysiology (U.H.), Oulu University Hospital, Finland Paris Descartes University (L.L., J.-L.C., S.-Y.Z.), Imagine Institute, Paris Laboratory of Human Genetics of Infectious Diseases (J.-L.C., S.-Y.Z.), Necker Branch, INSERM UMR 1163, Necker Hospital for Sick Children, Paris Pediatric Hematology-Immunology Unit (J.-L.C.), Necker Hospital for Sick Children, Paris, France Howard Hughes Medical Institute (J.-L.C.), New York, NY Adult Immunodeficiency Unit (M.R.J.S.), Infectious Diseases, Inflammation Center, University of Helsinki and HUS Helsinki University Hospital, Finland and Rare Disease Center and Pediatric Research Center (M.R.J.S.Cambridge, Mass. Giles Laboratory of Human Genetics of Infectious Diseases (J.C., J.-L.C., S.-Y.Z.), Rockefeller Branch, The Rockefeller University, New York, NY Department of Neurology (L.T., S.W.), Oulu University Hospital Institute for Molecular Medicine Finland (J.L., J.S.), HiLIFE, and The Folkhälsan Research Center and Medicum (J.L.), University of Helsinki, Finland Centre for Molecular Medicine Norway (J.S.), University of Oslo, Norway Department of Clinical Genetics (M.K., O.K.), Oulu University Hospital, Finland Department of Medical Microbiology (T.V.), Turku University Hospital and Institute of Biomedicine, University of Turku, Finland Department of Clinical Neurophysiology (U.H.), Oulu University Hospital, Finland Paris Descartes University (L.L., J.-L.C., S.-Y.Z.), Imagine Institute, Paris Laboratory of Human Genetics of Infectious Diseases (J.-L.C., S.-Y.Z.), Necker Branch, INSERM UMR 1163, Necker Hospital for Sick Children, Paris Pediatric Hematology-Immunology Unit (J.-L.C.), Necker Hospital for Sick Children, Paris, France Howard Hughes Medical Institute (J.-L.C.), New York, NY Adult Immunodeficiency Unit (M.R.J.S.), Infectious Diseases, Inflammation Center, University of Helsinki and HUS Helsinki University Hospital, Finland and Rare Disease Center and Pediatric Research Center (M.R.J.S.), Children and Adolescents, University of Helsinki and HUS Helsinki University Hospital, Finland.įrom the Department of Internal Medicine (T.H., T.P.), Oulu University Hospital, Finland Research Unit of Biomedicine (T.H., V.G., P.Å.), University of Oulu, Finland St. ![]() From the Department of Internal Medicine (T.H., T.P.), Oulu University Hospital, Finland Research Unit of Biomedicine (T.H., V.G., P.Å.), University of Oulu, Finland St. ![]()
0 Comments
Leave a Reply. |